Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 048892/0364 | |
| Pages: | 7 |
| | Recorded: | 04/15/2019 | | |
Attorney Dkt #: | Q244489 |
Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 047364 FRAME: 0979. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16097028
|
Filing Dt:
|
10/26/2018
|
Publication #:
|
|
Pub Dt:
|
03/21/2019
| | | | |
Title:
|
COMPOSITION COMPRISING NAPHTHOQUINONE-BASED COMPOUND AS ACTIVE INGREDIENT, FOR PREVENTING OR AMELIORATING FATIGUE, CACHEXIA, PAIN, COGNITIVE DECLINE AND HEMATOPOIETIC STEM CELL REDUCTION WHICH ARE SIDE EFFECTS RELATED TO ANTICANCER DRUG TREATMENT
|
|
Assignee
|
|
|
460, IKSAN-DAERO IKSAN-SI |
JEOLLABUK-DO, KOREA, REPUBLIC OF 54538 |
|
Correspondence name and address
|
|
SUGHRUE MION PLLC
|
|
2100 PENNSYLVANIA AVENUE, NW
|
|
SUITE 800
|
|
WASHINGTON, DC 20037-3213
|
Search Results as of:
09/23/2024 05:09 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|